Agency Forms Undergoing Paperwork Reduction Act Review

• Published date: 26 January 2021
• Citation: 86 FR 7092
• Record Number: 2021-01619
• Section: Notices
• Court: Centers For Disease Control And Prevention,Health And Human Services Department

7092

Federal Register / Vol. 86, No. 15 / Tuesday, January 26, 2021 / Notices

FEDERAL RESERVE SYSTEM

Formations of, Acquisitions by, and

Mergers of Bank Holding Companies

The companies listed in this notice

have applied to the Board for approval,

pursuant to the Bank Holding Company

Act of 1956 (12 U.S.C. 1841 et seq.)

(BHC Act), Regulation Y (12 CFR part

225), and all other applicable statutes

and regulations to become a bank

holding company and/or to acquire the

assets or the ownership of, control of, or

the power to vote shares of a bank or

bank holding company and all of the

banks and nonbanking companies

owned by the bank holding company,

including the companies listed below.

The public portions of the

applications listed below, as well as

other related filings required by the

Board, if any, are available for

immediate inspection at the Federal

Reserve Bank(s) indicated below and at

the offices of the Board of Governors.

This information may also be obtained

on an expedited basis, upon request, by

contacting the appropriate Federal

Reserve Bank and from the Board’s

Freedom of Information Office at

https://www.federalreserve.gov/foia/

request.htm. Interested persons may

express their views in writing on the

standards enumerated in the BHC Act

(12 U.S.C. 1842(c)).

Comments regarding each of these

applications must be received at the

Reserve Bank indicated or the offices of

the Board of Governors, Ann E.

Misback, Secretary of the Board, 20th

Street and Constitution Avenue NW,

Washington DC 20551–0001, not later

than February 25, 2021.

A. Federal Reserve Bank of San

Francisco (Sebastian Astrada, Director,

Applications) 101 Market Street, San

Francisco, California 94105–1579: 1. St.

Laurent Investments LLC, Vancouver,

Washington; to become a bank holding

company by acquiring People’s Bank of

Commerce, Medford, Oregon.

Board of Governors of the Federal Reserve

System, January 21, 2021.

Michele Taylor Fennell,

Deputy Associate Secretary of the Board.

[FR Doc. 2021–01690 Filed 1–25–21; 8:45 am]

BILLING CODE P

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Centers for Disease Control and

Prevention

[30Day–21–0728]

Agency Forms Undergoing Paperwork

Reduction Act Review

In accordance with the Paperwork

Reduction Act of 1995, the Centers for

Disease Control and Prevention (CDC)

has submitted the information

collection request titled National

Notifiable Diseases Surveillance System

(NNDSS) to the Office of Management

and Budget (OMB) for review and

approval. CDC previously published a

‘‘Proposed Data Collection Submitted

for Public Comment and

Recommendations’’ notice on October

23, 2020 to obtain comments from the

public and affected agencies. CDC did

not receive comments related to the

previous notice. This notice serves to

allow an additional 30 days for public

and affected agency comments.

CDC will accept all comments for this

proposed information collection project.

The Office of Management and Budget

is particularly interested in comments

that:

(a) Evaluate whether the proposed

collection of information is necessary

for the proper performance of the

functions of the agency, including

whether the information will have

practical utility;

(b) Evaluate the accuracy of the

agencies estimate of the burden of the

proposed collection of information,

including the validity of the

methodology and assumptions used;

(c) Enhance the quality, utility, and

clarity of the information to be

collected;

(d) Minimize the burden of the

collection of information on those who

are to respond, including, through the

use of appropriate automated,

electronic, mechanical, or other

technological collection techniques or

other forms of information technology,

e.g., permitting electronic submission of

responses; and

(e) Assess information collection

costs.

To request additional information on

the proposed project or to obtain a copy

of the information collection plan and

instruments, call (404) 639–7570.

Comments and recommendations for the

proposed information collection should

be sent within 30 days of publication of

this notice to www.reginfo.gov/public/

do/PRAMain. Find this particular

information collection by selecting

‘‘Currently under 30-day Review—Open

for Public Comments’’ or by using the

search function. Direct written

comments and/or suggestions regarding

the items contained in this notice to the

Attention: CDC Desk Officer, Office of

Management and Budget, 725 17th

Street NW, Washington, DC 20503 or by

fax to (202) 395–5806. Provide written

comments within 30 days of notice

publication.

Proposed Project

National Notifiable Diseases

Surveillance System (NNDSS) (0920–

0728, Exp. 4/30/23)—Revision—Center

for Surveillance, Epidemiology and

Laboratory Services (CSELS), Centers for

Disease Control and Prevention (CDC).

Background and Brief Description

The Public Health Services Act (42

U.S.C. 241) authorizes CDC to

disseminate nationally notifiable

condition information. The National

Notifiable Diseases Surveillance System

(NNDSS) is based on data collected at

the state, territorial and local levels as

a result of legislation and regulations in

those jurisdictions that require health

care providers, medical laboratories,

and other entities to submit health-

related data on reportable conditions to

public health departments. These

reportable conditions, which include

infectious and non-infectious diseases,

vary by jurisdiction depending upon

each jurisdiction’s health priorities and

needs. Each year, the Council of State

and Territorial Epidemiologists (CSTE),

supported by CDC, determines which

reportable conditions should be

designated nationally notifiable or

under standardized surveillance.

CDC requests a three-year approval for

a Revision for the NNDSS, (OMB

Control No. 0920–0728, Expiration Date

04/30/2023). This Revision includes

requests for approval to: (1) Receive case

notification data for Multisystem

Inflammatory Syndrome (MIS)

associated with Coronavirus Disease

2019 (COVID–19); (2) receive new

disease-specific data elements for

Anthrax, Brucellosis,

Campylobacteriosis, Cholera,

Cryptosporidiosis, Hansen’s Disease,

Leptospirosis, Melioidosis, MIS

associated with COVID–19, COVID–19,

S. Paratyphi Infection, S. Typhi

Infection, Salmonellosis, STEC,

Shigellosis, and Vibriosis; and (3)

Receive new vaccine-related data

elements for all conditions.

The NNDSS currently facilitates the

submission and aggregation of case

notification data voluntarily submitted

to CDC from 60 jurisdictions: Public

health departments in every U.S. state,

New York City, Washington DC, five

VerDate Sep<11>2014 20:59 Jan 25, 2021 Jkt 253001 PO 00000 Frm 00033 Fmt 4703 Sfmt 4703 E:\FR\FM\26JAN1.SGM 26JAN1

7093

Federal Register / Vol. 86, No. 15 / Tuesday, January 26, 2021 / Notices

U.S. territories (American Samoa, the

Commonwealth of Northern Mariana

Islands, Guam, Puerto Rico, and the U.S.

Virgin Islands), and three freely

associated states (Federated States of

Micronesia, the Republic of the

Marshall Islands, and the Republic of

Palau). This information is shared

across jurisdictional boundaries and

both surveillance and prevention and

control activities are coordinated at

regional and national levels.

Approximately 90% of case

notifications are encrypted and

submitted to NNDSS electronically from

already existing databases by automated

electronic messages. When automated

transmission is not possible, case

notifications are faxed, emailed,

uploaded to a secure network or entered

into a secure website. All case

notifications that are faxed or emailed

are done so in the form of an aggregate

weekly or annual report, not individual

cases. These different mechanisms used

to send case notifications to CDC vary

by the jurisdiction and the disease or

condition. Jurisdictions remove most

personally identifiable information (PII)

before data are submitted to CDC, but

some data elements (e.g., date of birth,

date of diagnosis, county of residence)

could potentially be combined with

other information to identify

individuals. Private information is not

disclosed unless otherwise compelled

by law. All data are treated in a secure

manner consistent with the technical,

administrative, and operational controls

required by the Federal Information

Security Management Act of 2002

(FISMA) and the 2010 National Institute

of Standards and Technology (NIST)

Recommended Security Controls for

Federal Information Systems and

Organizations. Weekly tables of

nationally notifiable diseases are

available through CDC WONDER and

data.cdc.gov. Annual summaries of

finalized nationally notifiable disease

data are published on CDC WONDER

and data.cdc.gov and disease-specific

data are published by individual CDC

programs.

The burden estimates include the

number of hours that the public health

department uses to process and send

case notification data from their

jurisdiction to CDC. Specifically, the

burden estimates include separate

burden hours incurred for automated

and non-automated transmissions,

separate weekly burden hours incurred

for modernizing surveillance systems as

part of NNDSS Modernization Initiative

(NMI) implementation, separate burden

hours incurred for annual data

reconciliation and submission, and

separate one-time burden hours

incurred for the addition of new

diseases and data elements. The burden

estimates for the one-time burden for

reporting jurisdictions are for the

addition of case notification data for

MIS associated with COVID–19; disease-

specific data elements for Anthrax,

Brucellosis, Campylobacteriosis,

Cholera, Cryptosporidiosis, Hansen’s

Disease, Leptospirosis, Melioidosis, MIS

associated with COVID–19, COVID–19,

S. Paratyphi Infection, S. Typhi

Infection, Salmonellosis, STEC,

Shigellosis, and Vibriosis; and vaccine

data elements for all diseases. The

estimated annual burden for the 257

respondents is 18,954 hours.

E

STIMATED

A

NNUALIZED

B

URDEN

H

OURS

Type of respondents Form name Number of

respondents

Number of

responses per

respondent

Average

burden per

response

(in hours)

States .............................................................. Weekly (Automated) ....................................... 50 52 20/60

States .............................................................. Weekly (Non-automated) ............................... 10 52 2

States .............................................................. Weekly (NMI Implementation) ........................ 50 52 4

States .............................................................. Annual ............................................................ 50 1 75

States .............................................................. One-time Addition of Diseases and Data Ele-

ments. 50 1 12

Territories ........................................................ Weekly (Automated) ....................................... 5 52 20/60

Territories ........................................................ Weekly, Quarterly (Non-automated) .............. 5 56 20/60

Territories ........................................................ Weekly (NMI Implementation) ........................ 5 52 4

Territories ........................................................ Annual ............................................................ 5 1 5

Territories ........................................................ One-time Addition of Diseases and Data Ele-

ments. 5 1 12

Freely Associated States ................................ Weekly (Automated) ....................................... 3 52 20/60

Freely Associated States ................................ Weekly, Quarterly (Non-automated) .............. 3 56 20/60

Freely Associated States ................................ Annual ............................................................ 3 1 5

Freely Associated States ................................ One-time Addition of Diseases and Data Ele-

ments. 3 1 12

Cities ............................................................... Weekly (Automated) ....................................... 2 52 20/60

Cities ............................................................... Weekly (Non-automated) ............................... 2 52 2

Cities ............................................................... Weekly (NMI Implementation) ........................ 2 52 4

Cities ............................................................... Annual ............................................................ 2 1 75

Cities ............................................................... One-time Addition of Diseases and Data Ele-

ments. 2 1 12

Jeffrey M. Zirger,

Lead, Information Collection Review Office,

Office of Scientific Integrity, Office of Science,

Centers for Disease Control and Prevention.

[FR Doc. 2021–01619 Filed 1–25–21; 8:45 am]

BILLING CODE 4163–18–P

VerDate Sep<11>2014 20:59 Jan 25, 2021 Jkt 253001 PO 00000 Frm 00034 Fmt 4703 Sfmt 9990 E:\FR\FM\26JAN1.SGM 26JAN1